Link K H, Aigner K R, Peschau K, Warthona M, Schwemmle K, Danenberg P V
Abteilung für Allgemein- und Thoraxchirurgie, Justus-Liebig-Universität, Giessen, Federal Republic of Germany.
Cancer Chemother Pharmacol. 1988;22(1):58-62. doi: 10.1007/BF00254182.
To determine the optimal concentration time factors for the fluoropyrimidines 5-fluorouracil (FU), 5-fluorouridine (FUR), and 5-fluoro-2'-deoxyuridine (FUdR) in regional chemotherapy, we tested these drugs against the colorectal carcinoma cell line HT 29 at various dosages and exposure times. The measure of cytotoxicity used was the degree of inhibition of colony formation in soft agar after drug treatment compared with untreated control cells. Colonies were visible after 6 days of growth in soft agar, so the initial evaluation of toxicity was done at this time. Additional colonies were found 10 and 16 days after the first evaluation, so the dishes containing the treated cells were also evaluated for this delayed growth phenomenon ("regrowth"), which we considered to be due to a cell growth inhibition effect of the drugs rather than a cytocidal effect. Exposure times of the cells to the drugs ranged from 5 min to 24 h and the doses, between 0.01 and 1000 micrograms/ml. The toxicity of FUdR was concentration-dependent, but its time dependence ceased after a relatively short exposure time. There was a cell population that was not susceptible to FUdR regardless of dose and exposure time; consequently, FUdR treatment was always accompanied by substantial regrowth of colonies. With FU and FUR, conditions could be achieved that resulted in complete cell death (no regrowth), but high concentrations and long exposure times were required with FU. With FUR, on the other hand, both cytostasis and cytotoxicity could be achieved with substantially lower doses and shorter exposure times than with FU. These results indicate that FUR has the potential to be an effective drug in chemotherapy protocols not involving systemic administration.
为确定氟嘧啶类药物5-氟尿嘧啶(FU)、5-氟尿苷(FUR)和5-氟-2'-脱氧尿苷(FUdR)在区域化疗中的最佳浓度-时间因素,我们在不同剂量和暴露时间下,用这些药物对结肠癌细胞系HT 29进行了测试。所采用的细胞毒性测量方法是,将药物处理后的细胞与未处理的对照细胞相比,测定软琼脂中集落形成的抑制程度。在软琼脂中生长6天后可见集落,因此此时进行毒性的初步评估。在首次评估后的第10天和第16天发现了更多集落,所以对含有处理后细胞的培养皿也评估了这种延迟生长现象(“再生长”),我们认为这是由于药物的细胞生长抑制作用而非细胞杀伤作用所致。细胞与药物的暴露时间为5分钟至24小时,剂量为0.01至1000微克/毫升。FUdR的毒性呈浓度依赖性,但其时间依赖性在相对较短的暴露时间后就停止了。存在一个细胞群体,无论剂量和暴露时间如何,对FUdR均不敏感;因此,FUdR处理后集落总会大量再生长。对于FU和FUR,可实现导致细胞完全死亡(无再生长)的条件,但FU需要高浓度和长时间暴露。另一方面,如果使用FUR,与FU相比,在剂量显著更低、暴露时间更短的情况下,既能实现细胞生长停滞,又能实现细胞毒性。这些结果表明,FUR有潜力成为一种不涉及全身给药化疗方案中的有效药物。